Wall Street only has eyes for the coronavirus news, Jim Cramer says. And with the selloff likely to continue next week, he's got your defensive game plan.

Don't be too glib about recession talk, says Jim Cramer. Instead, be informed.

Bristol-Myers Squibb shares edged higher Thursday after the pharmaceutical group said it has completed its $74 billion acquisition of cancer drug specialist Celgene Corp.

Bristol-Myers Squibb trades lower after the pharmaceutical giant reveals a recent trial involving one of its treatments for melanoma skin cancer did not meet its main objective.

Tesla CEO Musk discusses succession plans and Twitter with shareholders.

The company has made clear what it plans on the Las Vegas Strip, but it has a fast-approaching deadline.

Long-delayed futuristic looking electric vehicle will be in production by the middle of 2023